Un dosage sanguin de la ferritine est effectué pour confirmer l'hyperferritinémie.
FerritineSyndrome inflammatoire
#2
Quels tests complémentaires sont utiles ?
Des tests de fer sérique et de capacité de fixation du fer peuvent être réalisés.
Fer sériqueCapacité de fixation du fer
#3
L'hyperferritinémie est-elle toujours pathologique ?
Non, elle peut être due à des causes non pathologiques comme l'exercice intense.
Exercice physiqueInflammation
#4
Quels sont les niveaux normaux de ferritine ?
Les niveaux normaux varient entre 30 et 300 ng/mL selon le sexe et l'âge.
FerritineNormes biologiques
#5
Peut-on avoir une hyperferritinémie sans surcharge en fer ?
Oui, l'hyperferritinémie peut résulter d'inflammations ou d'infections.
InflammationInfection
Symptômes
5
#1
Quels sont les symptômes de l'hyperferritinémie ?
Souvent asymptomatique, elle peut causer fatigue, douleurs abdominales ou arthralgies.
FatigueDouleurs abdominales
#2
L'hyperferritinémie provoque-t-elle des douleurs ?
Elle peut entraîner des douleurs articulaires ou abdominales selon la cause sous-jacente.
Douleurs articulairesDouleurs abdominales
#3
Y a-t-il des signes cutanés associés ?
Des dépôts de fer peuvent causer des changements cutanés, comme une pigmentation accrue.
Pigmentation cutanéeDépôts de fer
#4
L'hyperferritinémie affecte-t-elle le foie ?
Oui, une surcharge en fer peut entraîner des lésions hépatiques et des douleurs hépatiques.
Lésions hépatiquesDouleurs hépatiques
#5
Peut-on avoir des symptômes neurologiques ?
Des troubles neurologiques peuvent survenir en cas de surcharge en fer dans le cerveau.
Troubles neurologiquesSurcharge en fer
Prévention
5
#1
Comment prévenir l'hyperferritinémie ?
Éviter les suppléments de fer non nécessaires et surveiller les niveaux de ferritine.
Suppléments de ferSurveillance
#2
L'alimentation influence-t-elle la ferritine ?
Oui, une alimentation riche en fer peut augmenter les niveaux de ferritine.
AlimentationFer
#3
Les dons de sang aident-ils à prévenir ?
Oui, les dons réguliers peuvent aider à réduire les niveaux de fer dans le sang.
Dons de sangFer
#4
Faut-il éviter certains aliments ?
Limiter les aliments riches en fer et en vitamine C peut aider à contrôler la ferritine.
Aliments riches en ferVitamine C
#5
Les maladies chroniques augmentent-elles le risque ?
Oui, des maladies comme l'hémochromatose augmentent le risque d'hyperferritinémie.
HémochromatoseMaladies chroniques
Traitements
5
#1
Comment traiter l'hyperferritinémie ?
Le traitement dépend de la cause, incluant phlébotomies ou chélateurs de fer.
PhlébotomieChélateurs de fer
#2
Les phlébotomies sont-elles efficaces ?
Oui, elles réduisent le fer dans le sang et sont efficaces pour la surcharge en fer.
PhlébotomieSurcharge en fer
#3
Quels médicaments peuvent être utilisés ?
Des chélateurs de fer comme la déférasirox peuvent être prescrits pour réduire le fer.
DéférasiroxChélateurs de fer
#4
Y a-t-il des traitements naturels ?
Une alimentation équilibrée et riche en antioxydants peut aider à gérer l'hyperferritinémie.
Alimentation équilibréeAntioxydants
#5
Quand consulter un spécialiste ?
Il est conseillé de consulter un hématologue en cas de niveaux très élevés de ferritine.
HématologieFerritine
Complications
5
#1
Quelles sont les complications possibles ?
Les complications incluent des dommages au foie, au cœur et aux articulations.
Dommages hépatiquesCardiomyopathie
#2
L'hyperferritinémie peut-elle causer le diabète ?
Oui, une surcharge en fer peut être associée à un risque accru de diabète.
DiabèteSurcharge en fer
#3
Y a-t-il un risque de cancer ?
Certaines études suggèrent un lien entre l'hyperferritinémie et un risque accru de cancer.
CancerHyperferritinémie
#4
Comment l'hyperferritinémie affecte-t-elle le cœur ?
Elle peut entraîner des cardiomyopathies et des arythmies cardiaques.
CardiomyopathieArythmies
#5
Des problèmes articulaires peuvent-ils survenir ?
Oui, l'accumulation de fer peut provoquer des douleurs et des inflammations articulaires.
Douleurs articulairesInflammation
Facteurs de risque
5
#1
Quels sont les facteurs de risque principaux ?
Les antécédents familiaux, les maladies hépatiques et les transfusions fréquentes augmentent le risque.
Antécédents familiauxTransfusions sanguines
#2
L'âge influence-t-il le risque ?
Oui, le risque d'hyperferritinémie augmente avec l'âge, surtout chez les hommes.
ÂgeHyperferritinémie
#3
Les maladies génétiques jouent-elles un rôle ?
Oui, des maladies comme l'hémochromatose héréditaire augmentent le risque.
HémochromatoseMaladies génétiques
#4
Le sexe influence-t-il le risque ?
Oui, les hommes sont généralement plus à risque que les femmes avant la ménopause.
SexeMénopause
#5
Les habitudes alimentaires sont-elles un facteur ?
Oui, une alimentation riche en fer et en alcool peut augmenter le risque d'hyperferritinémie.
AlimentationAlcool
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperferritinémie : Questions médicales les plus fréquentes",
"headline": "Hyperferritinémie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperferritinémie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-15",
"dateModified": "2026-02-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperferritinémie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles du métabolisme du fer",
"url": "https://questionsmedicales.fr/mesh/D019189",
"about": {
"@type": "MedicalCondition",
"name": "Troubles du métabolisme du fer",
"code": {
"@type": "MedicalCode",
"code": "D019189",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.565"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hyperferritinémie",
"alternateName": "Hyperferritinemia",
"code": {
"@type": "MedicalCode",
"code": "D000085583",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kate F Kernan",
"url": "https://questionsmedicales.fr/author/Kate%20F%20Kernan",
"affiliation": {
"@type": "Organization",
"name": "Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA."
}
},
{
"@type": "Person",
"name": "Alberto Piperno",
"url": "https://questionsmedicales.fr/author/Alberto%20Piperno",
"affiliation": {
"@type": "Organization",
"name": "Centre for Rare Disease-Disorders of Iron Metabolism, Fondazione IRCCS, San Gerardo dei Tintori, European Reference Network-EuroBloodNet, 20900 Monza, Italy."
}
},
{
"@type": "Person",
"name": "Sara Pelucchi",
"url": "https://questionsmedicales.fr/author/Sara%20Pelucchi",
"affiliation": {
"@type": "Organization",
"name": "School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy."
}
},
{
"@type": "Person",
"name": "Raffaella Mariani",
"url": "https://questionsmedicales.fr/author/Raffaella%20Mariani",
"affiliation": {
"@type": "Organization",
"name": "Centre for Rare Disease-Disorders of Iron Metabolism, Fondazione IRCCS, San Gerardo dei Tintori, European Reference Network-EuroBloodNet, 20900 Monza, Italy."
}
},
{
"@type": "Person",
"name": "Gunnar Lachmann",
"url": "https://questionsmedicales.fr/author/Gunnar%20Lachmann",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, D-13353 Berlin, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Development and Validation of a Bedside Dengue Severity Score for Predicting Severe Dengue in Children.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36757000",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Retrospective Analysis of Severe Dengue by Dengue Virus Serotypes in a Population with Social Security, Mexico 2023.",
"datePublished": "2024-05-13",
"url": "https://questionsmedicales.fr/article/38793650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/v16050769"
}
},
{
"@type": "ScholarlyArticle",
"name": "Spontaneous retroperitoneal haematoma in severe dengue: A case report.",
"datePublished": "2023-10-01",
"url": "https://questionsmedicales.fr/article/37778744",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/tmi.13936"
}
},
{
"@type": "ScholarlyArticle",
"name": "Aspergillus coinfection in critically Ill patients with severe dengue.",
"datePublished": "2023-09-22",
"url": "https://questionsmedicales.fr/article/37866267",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jiph.2023.09.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dengue virus serotype did not contribute to clinical severity or mortality in Taiwan's largest dengue outbreak in 2015.",
"datePublished": "2023-11-06",
"url": "https://questionsmedicales.fr/article/37932817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40001-023-01454-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles du métabolisme du fer",
"item": "https://questionsmedicales.fr/mesh/D019189"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hyperferritinémie",
"item": "https://questionsmedicales.fr/mesh/D000085583"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperferritinémie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperferritinémie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperferritinémie",
"description": "Comment diagnostiquer l'hyperferritinémie ?\nQuels tests complémentaires sont utiles ?\nL'hyperferritinémie est-elle toujours pathologique ?\nQuels sont les niveaux normaux de ferritine ?\nPeut-on avoir une hyperferritinémie sans surcharge en fer ?",
"url": "https://questionsmedicales.fr/mesh/D000085583?mesh_terms=Severe+Dengue#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperferritinémie",
"description": "Quels sont les symptômes de l'hyperferritinémie ?\nL'hyperferritinémie provoque-t-elle des douleurs ?\nY a-t-il des signes cutanés associés ?\nL'hyperferritinémie affecte-t-elle le foie ?\nPeut-on avoir des symptômes neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D000085583?mesh_terms=Severe+Dengue#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperferritinémie",
"description": "Comment prévenir l'hyperferritinémie ?\nL'alimentation influence-t-elle la ferritine ?\nLes dons de sang aident-ils à prévenir ?\nFaut-il éviter certains aliments ?\nLes maladies chroniques augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D000085583?mesh_terms=Severe+Dengue#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperferritinémie",
"description": "Comment traiter l'hyperferritinémie ?\nLes phlébotomies sont-elles efficaces ?\nQuels médicaments peuvent être utilisés ?\nY a-t-il des traitements naturels ?\nQuand consulter un spécialiste ?",
"url": "https://questionsmedicales.fr/mesh/D000085583?mesh_terms=Severe+Dengue#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperferritinémie",
"description": "Quelles sont les complications possibles ?\nL'hyperferritinémie peut-elle causer le diabète ?\nY a-t-il un risque de cancer ?\nComment l'hyperferritinémie affecte-t-elle le cœur ?\nDes problèmes articulaires peuvent-ils survenir ?",
"url": "https://questionsmedicales.fr/mesh/D000085583?mesh_terms=Severe+Dengue#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperferritinémie",
"description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il le risque ?\nLes maladies génétiques jouent-elles un rôle ?\nLe sexe influence-t-il le risque ?\nLes habitudes alimentaires sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D000085583?mesh_terms=Severe+Dengue#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperferritinémie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un dosage sanguin de la ferritine est effectué pour confirmer l'hyperferritinémie."
}
},
{
"@type": "Question",
"name": "Quels tests complémentaires sont utiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fer sérique et de capacité de fixation du fer peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "L'hyperferritinémie est-elle toujours pathologique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle peut être due à des causes non pathologiques comme l'exercice intense."
}
},
{
"@type": "Question",
"name": "Quels sont les niveaux normaux de ferritine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux normaux varient entre 30 et 300 ng/mL selon le sexe et l'âge."
}
},
{
"@type": "Question",
"name": "Peut-on avoir une hyperferritinémie sans surcharge en fer ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperferritinémie peut résulter d'inflammations ou d'infections."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hyperferritinémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent asymptomatique, elle peut causer fatigue, douleurs abdominales ou arthralgies."
}
},
{
"@type": "Question",
"name": "L'hyperferritinémie provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des douleurs articulaires ou abdominales selon la cause sous-jacente."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépôts de fer peuvent causer des changements cutanés, comme une pigmentation accrue."
}
},
{
"@type": "Question",
"name": "L'hyperferritinémie affecte-t-elle le foie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surcharge en fer peut entraîner des lésions hépatiques et des douleurs hépatiques."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes neurologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques peuvent survenir en cas de surcharge en fer dans le cerveau."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperferritinémie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les suppléments de fer non nécessaires et surveiller les niveaux de ferritine."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la ferritine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fer peut augmenter les niveaux de ferritine."
}
},
{
"@type": "Question",
"name": "Les dons de sang aident-ils à prévenir ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les dons réguliers peuvent aider à réduire les niveaux de fer dans le sang."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Limiter les aliments riches en fer et en vitamine C peut aider à contrôler la ferritine."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'hémochromatose augmentent le risque d'hyperferritinémie."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hyperferritinémie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause, incluant phlébotomies ou chélateurs de fer."
}
},
{
"@type": "Question",
"name": "Les phlébotomies sont-elles efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent le fer dans le sang et sont efficaces pour la surcharge en fer."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent être utilisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des chélateurs de fer comme la déférasirox peuvent être prescrits pour réduire le fer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en antioxydants peut aider à gérer l'hyperferritinémie."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter un hématologue en cas de niveaux très élevés de ferritine."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des dommages au foie, au cœur et aux articulations."
}
},
{
"@type": "Question",
"name": "L'hyperferritinémie peut-elle causer le diabète ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surcharge en fer peut être associée à un risque accru de diabète."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre l'hyperferritinémie et un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Comment l'hyperferritinémie affecte-t-elle le cœur ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des cardiomyopathies et des arythmies cardiaques."
}
},
{
"@type": "Question",
"name": "Des problèmes articulaires peuvent-ils survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'accumulation de fer peut provoquer des douleurs et des inflammations articulaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque principaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les maladies hépatiques et les transfusions fréquentes augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'hyperferritinémie augmente avec l'âge, surtout chez les hommes."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques jouent-elles un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'hémochromatose héréditaire augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes sont généralement plus à risque que les femmes avant la ménopause."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fer et en alcool peut augmenter le risque d'hyperferritinémie."
}
}
]
}
]
}
Centre for Rare Disease-Disorders of Iron Metabolism, Fondazione IRCCS, San Gerardo dei Tintori, European Reference Network-EuroBloodNet, 20900 Monza, Italy.
Centre for Rare Disease-Disorders of Iron Metabolism, Fondazione IRCCS, San Gerardo dei Tintori, European Reference Network-EuroBloodNet, 20900 Monza, Italy.
Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, D-13353 Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, D-13353 Berlin, Germany.
Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, D-13353 Berlin, Germany.
Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, D-13353 Berlin, Germany.
Department of Medical and Surgical Sciences, Università degli Studi di Modena e Reggio Emilia, Via del Pozzo 71, 41124 Modena, Italy.
Internal Medicine and Centre for Hemochromatosis and Hereditary Liver Diseases, Azienda Ospedaliero-Universitaria di Modena Policlinico, 41124 Modena, Italy.
Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Augustenburger Platz 1, D-13353 Berlin, Germany.
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany.
To develop and validate a bedside dengue severity score in children less than 12 years for predicting severe dengue disease....
We carried out an analysis of data on the clinical and laboratory parameters of patients with confirmed dengue, hospitalized in October, 2019 at our center. A comprehensive patient's score was develop...
Severe dengue was predicted by the dengue severity score with a sensitivity of 86.75% (95% CI 77.52%-93.19%), specificity of 98.25% (95% CI 95.56-99.52%), a positive predictive value of 95.34% (95% CI...
The proposed bedside dengue severity scoring system was found to have good validity. Validating the score in different settings and patient populations is suggested....
Risk factors for severe dengue manifestations have been attributed to various factors, including specific serotypes, sex, and age. Mexico has seen the re-emergence of DENV-3, which has not circulated ...
To describe dengue serotypes by age, sex, and their association with disease severity in dengue-positive serum samples from epidemiological surveillance system units....
A descriptive analysis was conducted to evaluate the frequency of dengue severity by sex, age, disease quarter, geographical location, and dengue virus serotypes. The study was conducted using laborat...
In 2023, 10,441 samples were processed for dengue RT-qPCR at the IMSS, with a predominance of serotype DENV-3 (64.4%). The samples were mostly from women (52.0%) and outpatient cases (63.3%). The dist...
Women, age groups at the extremes of life, and the DENV-2 serotype presented severe risk of dengue in a population with social security in Mexico during 2023....
Dengue is endemic in over 100 countries worldwide, predominantly in the subtropical and tropical regions and the incidence has been increasing globally. Patients with severe dengue may develop massive...
In 2014-2015, a significant outbreak of dengue fever occurred in southern Taiwan, with a subsequent decline in dengue incidence. Despite this, there is emerging concern about virus-associated aspergil...
Dengue virus serotype 2 (DENV-2) was the major serotype in the 2015 dengue outbreak in Taiwan, while DENV-1 and DENV-3 were dominant between 2005 and 2014. We aimed to investigate whether DENV-2 contr...
We collected serum samples from dengue patients to detect the presence of DENV and determine the serotypes by using quantitative reverse transcription-polymerase chain reaction. Our cohorts comprised ...
The results suggested that DENV-1 persisted and circulated, while DENV-2 was dominant during the dengue outbreak that occurred between September and December 2015. However, DENV-2 did not directly con...
Our findings highlight the importance of timely serological testing in elderly patients to identify potential secondary infections and focus on the meticulous management of elderly patients with DM or...
Dengue virus is a flavivirus transmitted by...
To describe the epidemiology, clinical characteristics, and outcomes among international travelers with severe dengue or dengue with warning signs as defined by the 2009 World Health Organization clas...
Retrospective chart review and analysis of travelers with complicated dengue reported to GeoSentinel from January 2007 through July 2022....
20 of 71 international GeoSentinel sites....
Returning travelers with complicated dengue....
Routinely collected surveillance data plus chart review with abstraction of clinical information using predefined grading criteria to characterize the manifestations of complicated dengue....
Of 5958 patients with dengue, 95 (2%) had complicated dengue. Eighty-six (91%) patients had a supplemental questionnaire completed. Eighty-five of 86 (99%) patients had warning signs, and 27 (31%) wer...
Data for some variables could not be retrieved by chart review for some patients. The generalizability of our observations may be limited....
Complicated dengue is relatively rare in travelers. Clinicians should monitor patients with dengue closely for warning signs that may indicate progression to severe disease. Risk factors for developin...
Centers for Disease Control and Prevention, International Society of Travel Medicine, Public Health Agency of Canada, and GeoSentinel Foundation....
Dengue is a disease that accounts for a major morbidity and mortality in Honduras....
This descriptive study used an analytical component based on the data from the National Virology Laboratory between 2016-2022. Ordinal logistic regression was used to identify the factors associated w...
Overall, 14,687 dengue cases were included; 50.1% had DWOS, 36.5% had DWS, and 13.4% had SD. Patients that were more associated with a higher probability of DWS and SD were patients in the age groups ...
During the study period, dengue presented endemic behavior, with peaks consistent with the last two epidemics in Honduras in 2015 and 2019. The main factors associated with dengue severity were age< 1...
Dengue is the most common vector-borne viral disease worldwide. Most cases are mild, but some evolve into severe dengue (SD), with high lethality. Therefore, it is important to identify biomarkers of ...
One hundred forty-five confirmed dengue cases (median age, 42; range <1-91 years), enrolled from February 2018 to March 2020, were selected from an ongoing study of suspected arboviral infections in m...
Multiple, readily available factors were associated with SD in this population. These findings will aid in the early detection of potentially severe dengue cases and inform the development of new prog...
Pediatric dengue and sepsis share clinical and pathophysiologic aspects. Multiple inflammatory and regulatory cytokines, decoy receptors and vascular permeability factors have been implicated in the p...
We evaluated the concentration levels of 11 soluble factors with proinflammatory, regulatory and vascular permeability involvement, in plasma from children with dengue or sepsis, both clinically rangi...
During early acute infection, children with sepsis exhibited specific higher concentration levels of IL-6, vascular endothelial growth factor (VEGF), and its soluble decoy receptor II (sVEGFR2) and lo...
Dengue virus infection and septic processes in children are characterized by cytokine responses of a specific magnitude, pattern and kinetics, which are implicated in the pathophysiology and clinical ...
Hyperferritinemia in the critical phase of dengue infections may correlate with severe dengue ( sd ) disease, and our primary objective was to examine the association between ferritin level on day 1 o...
Retrospective cohort study of children with dengue 1 month to 16 years old with admission ferritin greater than or equal to 500 ng/mL requiring PICU admission. Demographics, clinical, and laboratory p...
None....
Fifty-five patients were admitted in the critical phase of dengue with median (interquartile range) ferritin levels of 8,105 ng/mL (2,350-15,765 ng/mL). Patients with at least one WHO sd category had ...
Hyperferritinemia in the critical phase of sd is associated with the number of 2009 WHO sd criteria present. Our data also indicate that many patients with sd recover well with supportive care....